Experts say the U.S. could see a spike in COVID-19 cases as we head into fall and winter. That possibility is renewing calls on Congress to approve more money for coronavirus relief.
Children younger than 5 could soon be eligible for a COVID-19 vaccine.
A fourth dose is already authorized in the U.S. for people 50 and older.
Consumer News: Baby formula shortage causing some retailers to limit sales, Richland Library offering healthcare services on Thursdays
New data shows COVID-19 hospitalizations and deaths are on track to rise for the first time in months, and the FDA is encouraging Americans to get either the Moderna or Pfizer vaccines over the Johnson & Johnson shot.
U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots.
DHEC reports 3,044 new cases of COVID-19 and eight additional virus related deaths in the state.
The Food and Drug Administration says it will hold three meetings in June to discuss vaccines for young children. It’s been nearly a year and a half since the first adult doses of COVID-19 vaccines were administered, yet vaccines are still not approved for children five and under.
The FDA said Friday it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for vaccines in tots and babies. The dates are tentative and regulators said they will provide more details later.
DHEC reports 2,074 new cases of COVID-19 and two new deaths in the state last week.
